Robinson MG - Search Results

1

Effect of sleep on swallowing, esophageal peristalsis, and acid clearance.

Orr WC, Johnson LF, Robinson MG. Orr WC, et al. Among authors: robinson mg. Gastroenterology. 1984 May;86(5 Pt 1):814-9. Gastroenterology. 1984. PMID: 6706065

2

Hypertensive peristalsis in the pathogenesis of chest pain: further exploration of the "nutcracker" esophagus.

Orr WC, Robinson MG. Orr WC, et al. Among authors: robinson mg. Am J Gastroenterol. 1982 Sep;77(9):604-7. Am J Gastroenterol. 1982. PMID: 7114023

3

The effects of swallowing frequency and transdermal scopolamine on esophageal acid clearance.

Allen ML, Orr WC, Woodruff DM, Duke JC, Robinson MG. Allen ML, et al. Among authors: robinson mg. Am J Gastroenterol. 1985 Sep;80(9):669-72. Am J Gastroenterol. 1985. PMID: 4036944

4

5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis.

Sutherland LR, Martin F, Greer S, Robinson M, Greenberger N, Saibil F, Martin T, Sparr J, Prokipchuk E, Borgen L. Sutherland LR, et al. Gastroenterology. 1987 Jun;92(6):1894-8. doi: 10.1016/0016-5085(87)90621-4. Gastroenterology. 1987. PMID: 3569765 Clinical Trial.

5

Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis. The Lansoprazole Group.

Castell DO, Richter JE, Robinson M, Sontag SJ, Haber MM. Castell DO, et al. Am J Gastroenterol. 1996 Sep;91(9):1749-57. Am J Gastroenterol. 1996. PMID: 8792693 Clinical Trial.

6

Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.

Sontag SJ, Kogut DG, Fleischmann R, Campbell DR, Richter J, Robinson M, McFarland M, Sabesin S, Lehman GA, Castell D. Sontag SJ, et al. Am J Gastroenterol. 1997 Mar;92(3):429-37. Am J Gastroenterol. 1997. PMID: 9068463 Clinical Trial.

7

H2-receptor antagonists and blood alcohol levels.

Miller TA, Robinson M. Miller TA, et al. Gastroenterology. 1992 Sep;103(3):1102-4. doi: 10.1016/0016-5085(92)90051-y. Gastroenterology. 1992. PMID: 1499912 No abstract available.

8

Does pH monitoring predict clinical course in esophagitis?

Robinson M. Robinson M. Gastroenterology. 1992 May;102(5):1816. doi: 10.1016/0016-5085(92)91753-q. Gastroenterology. 1992. PMID: 1568597 No abstract available.

9

Mesalamine capsules for the treatment of active Crohn's disease: results of a 16-week trial. Pentasa Crohn's Disease Study Group.

Singleton JW, Hanauer SB, Gitnick GL, Peppercorn MA, Robinson MG, Wruble LD, Krawitt EL. Singleton JW, et al. Among authors: robinson mg. Gastroenterology. 1993 May;104(5):1293-301. doi: 10.1016/0016-5085(93)90337-c. Gastroenterology. 1993. PMID: 8482443 Clinical Trial.

10

Budesonide enema for the treatment of active, distal ulcerative colitis and proctitis: a dose-ranging study. U.S. Budesonide enema study group.

Hanauer SB, Robinson M, Pruitt R, Lazenby AJ, Persson T, Nilsson LG, Walton-Bowen K, Haskell LP, Levine JG. Hanauer SB, et al. Gastroenterology. 1998 Sep;115(3):525-32. doi: 10.1016/s0016-5085(98)70131-3. Gastroenterology. 1998. PMID: 9721148 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results